Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Saved in:
Bibliographic Details
Title: Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.
Authors: Hiltunen, J.1 (AUTHOR) johanna.hiltunen@hus.fi, Parmanne, P.1 (AUTHOR), Sokka, T.2,3 (AUTHOR), Lamberg, T.4 (AUTHOR), Isomäki, P.5 (AUTHOR), Kaipiainen-Seppänen, O.6 (AUTHOR), Peltomaa, R.1 (AUTHOR), Uutela, T.7 (AUTHOR), Pirilä, L.8 (AUTHOR), Taimen, K.8 (AUTHOR), Kauppi, M. J.9,10 (AUTHOR), Yli-Kerttula, T.11 (AUTHOR), Tuompo, R.1 (AUTHOR), Relas, H.1 (AUTHOR), Kortelainen, S.8 (AUTHOR), Paalanen, K.2,3 (AUTHOR), Asikainen, J.2,3 (AUTHOR), Ekman, P.11 (AUTHOR), Santisteban, A.12 (AUTHOR), Vidqvist, K.-L.5 (AUTHOR)
Source: Rheumatology International. Jun2022, Vol. 42 Issue 6, p1015-1025. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01728172
DOI:10.1007/s00296-021-04955-8